Resumen de acción SPPI
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology drug products.
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
Competidores de Spectrum Pharmaceuticals, Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.03 |
| 52 Week High | US$1.57 |
| 52 Week Low | US$0.32 |
| Beta | 2.14 |
| 1 Month Change | 4.54% |
| 3 Month Change | -1.90% |
| 1 Year Change | 17.05% |
| 3 Year Change | -71.39% |
| 5 Year Change | -95.10% |
| Change since IPO | -99.25% |
Noticias y actualizaciones recientes
Recent updates
Analysts Just Made A Huge Upgrade To Their Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Forecasts
May 14
Earnings Update: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Just Reported And Analysts Are Boosting Their Estimates
May 12Spectrum plunges 28% after FDA scientists question poziotinib evidence for NSCLC
Sep 20Is Spectrum Pharmaceuticals (NASDAQ:SPPI) In A Good Position To Invest In Growth?
Sep 16Spectrum Pharmaceuticals stock jumps 10% afterhours on FDA nod for Rolvedon injection
Sep 09Spectrum Pharmaceuticals: Revisiting This 'Soap Opera'
Aug 21Spectrum Pharmaceuticals Q2 2022 Earnings Preview
Aug 10Here's Why We're A Bit Worried About Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Situation
Jun 04Spectrum Pharmaceuticals: Some Last Words
Feb 25Here's Why We're Watching Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Situation
Oct 05Spectrum Pharmaceuticals' CRL: There Is Very Little Clarity
Aug 12Spectrum's Big Approval: Any Day Now
Jul 29FDA initiates pre-approval inspection for Spectrum pharmaceuticals' ROLONTIS
Jun 01Here's Why We're Watching Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Situation
May 31We're Keeping An Eye On Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Rate
Feb 12Spectrum Pharma drops after announcing less-than-favorable Phase 2 data
Dec 22Here's What Spectrum Pharmaceuticals, Inc.'s (NASDAQ:SPPI) Shareholder Ownership Structure Looks Like
Dec 21Spectrum Pharma Is Down But Not Out
Nov 16Spectrum Shareholders In Limbo As FDA Delays Rolontis Decision Date, Agrees To Discuss Poziotinib
Nov 11Rentabilidad de los accionistas
| SPPI | US Biotechs | Mercado US | |
|---|---|---|---|
| 7D | 5.3% | -0.2% | 2.9% |
| 1Y | 17.0% | -1.0% | 22.2% |
Rentabilidad vs. Industria: SPPI superó al sector US Biotechs , que obtuvo un rendimiento del -3.7% el año pasado.
Rentabilidad vs. Mercado: SPPI superó al mercado US, que obtuvo un rendimiento del 19.3% el año pasado.
Volatilidad de los precios
| SPPI volatility | |
|---|---|
| SPPI Average Weekly Movement | 7.2% |
| Biotechs Industry Average Movement | 11.6% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: El precio de las acciones de SPPI ha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de SPPI ha disminuido de 15% a 7% en el último año.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1987 | 86 | Tom Riga | www.sppirx.com |
Resumen de fundamentos de Spectrum Pharmaceuticals, Inc.
| Estadísticas fundamentales de SPPI | |
|---|---|
| Capitalización bursátil | US$209.89m |
| Beneficios(TTM) | -US$67.71m |
| Ingresos (TTM) | US$25.73m |
8.2x
Ratio precio-ventas (PS)-3.1x
Ratio precio-beneficio (PE)¿Está SPPI sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de SPPI | |
|---|---|
| Ingresos | US$25.73m |
| Coste de los ingresos | US$2.86m |
| Beneficio bruto | US$22.87m |
| Otros gastos | US$90.58m |
| Beneficios | -US$67.71m |
Últimos beneficios comunicados
Mar 31, 2023
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -0.33 |
| Margen bruto | 88.90% |
| Margen de beneficio neto | -263.16% |
| Ratio deuda/patrimonio | 107.6% |
¿Cómo se ha desempeñado SPPI a largo plazo?
Ver rendimiento histórico y comparativa